During the webinar, we took a look at the Climb interface to see how practical workflows drive improved study efficiency, accuracy, and coordination. If you want to see Climb in action, be sure to check...
Non-GLP studies that support regulatory safety decisions are required by the FDA to be submitted in SEND, regardless of GLP status. Data collected in Climb™ can be efficiently converted into submission-ready SEND using Instem’s Submit™...
In vivo research is essential for new therapeutics, but minimizing animal burden is key. Instem’s Climb software helps ensure ethical research by supporting the principles of Reduction, Refinement, and Replacement.
ClimbData IntegrationPharmacokinetics and PharmacodynamicsPharmacologyResearch CollaborationStudy ManagementStudy Planning and ExecutionToxicologyWorkflow Automation
We’re excited to share the latest updates in Climb! This release brings powerful enhancements across Studies, Workflow, Animals, Orders, API & Webhooks, and more—plus important fixes to improve your experience.
Stay up to Date
Get expert tips, industry news, and fresh content delivered to your inbox.